)
Nova Leap Health (NLH) investor relations material
Nova Leap Health Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved record consolidated quarterly revenues, gross margin, and Adjusted EBITDA in Q3 2025, marking the best financial performance in company history.
Both Canadian and U.S. operating segments set new records for revenues, gross margin, and Adjusted EBITDA.
Net income turned positive in Q3 2025, reversing net losses from both Q2 2025 and Q3 2024.
Financial highlights
Q3 2025 revenues reached $8,264,326, up 3% from Q2 2025 and 29% year-over-year from Q3 2024.
Adjusted EBITDA for Q3 2025 was $670,706, a 16.1% increase over Q2 2025 and 76.9% higher than Q3 2024.
Gross profit margin was 39.6% in Q3 2025, compared to 40.2% in Q2 2025 and 38.0% in Q3 2024.
Income from operating activities was $418,553 in Q3 2025, up $68,114 from Q2 2025 and $210,443 from Q3 2024.
Net income for Q3 2025 was $426,171, compared to net losses of $484,008 in Q2 2025 and $207,871 in Q3 2024.
Outlook and guidance
Management highlighted a new, higher benchmark for quarterly Adjusted EBITDA, with Q2 and Q3 2025 both materially above prior averages.
Continued focus on disciplined growth, profitability, and long-term value creation, supported by strong operating cash flow and access to acquisition financing.
- TimeTickerHeadlineOpen
- FTV
2025 results beat guidance, with strong EPS growth and $1.6B in share repurchases. - WNC
Q4 2025 revenue was $321.5M with losses, but Parts & Services grew 33% year-over-year. - AAT
2025 FFO and income declined, but 2026 guidance and liquidity remain strong. - BGL
Tokenized gold coin and fintech platform drive growth, backed by mining and regulatory strength. - WAFD
All proposals passed with strong support; focus remains on innovation, competition, and shareholder value. - AVY
FY25 adjusted EPS up 1% to $9.53, $8.9B sales, and $861M returned to shareholders. - LLY
Q4 2025 revenue rose 43% to $19.3B; 2026 guidance set at $80–$83B revenue. - TKR
Q4 2025 outperformed; 2026 targets higher sales, margins, and EPS amid ongoing transformation. - POWL
Record backlog, strong orders, and margin expansion drive robust outlook for 2026. - AFG
Record 2025 results, strong ROE, and $707M+ capital returned, with robust 2026 outlook.
Next Nova Leap Health earnings date
Next Nova Leap Health earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)